Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
"Who might be able to join this trial:
- People who are 8 years of age or older
- People who have a known or suspected diagnosis of epilepsy
- People who are able to give informed consent themselves, or who have a parent, guardian, or legally authorized representative who is able to give consent on their behalf
- People who, if unable to give full written consent, are still able to give verbal agreement to participate
Who may not be able to join:
- People whose medical conditions are considered unstable or who may not be able to follow the study requirements, as determined by the trial investigators
- People who are unable to travel to the NIH (National Institutes of Health) for the study
Important: Always verify eligibility with the trial site directly before applying."
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yasser Tajali, M.D., National Institute of Neurological Disorders and Stroke (NINDS)
Phone: (301) 402-7686
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Screening and characterization of patients with drug-resistant epilepsy for epilepsy-related protocols
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.